Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Other Working Capital Changes (2023 - 2025)

Historic Other Working Capital Changes for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $1.6 million.

  • Zenas BioPharma's Other Working Capital Changes rose 18944.13% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 58777.17%. This contributed to the annual value of $7.7 million for FY2024, which is 12994.92% up from last year.
  • Per Zenas BioPharma's latest filing, its Other Working Capital Changes stood at $1.6 million for Q3 2025, which was up 18944.13% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Other Working Capital Changes ranged from a high of $8.2 million in Q4 2024 and a low of -$1.8 million during Q3 2024
  • Moreover, its 3-year median value for Other Working Capital Changes was -$401000.0 (2025), whereas its average is $891875.0.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 69897.44% in 2024, then plummeted by 13723.4% in 2025.
  • Over the past 3 years, Zenas BioPharma's Other Working Capital Changes (Quarter) stood at -$1.4 million in 2023, then soared by 698.97% to $8.2 million in 2024, then tumbled by 80.42% to $1.6 million in 2025.
  • Its Other Working Capital Changes stands at $1.6 million for Q3 2025, versus -$1.2 million for Q2 2025 and $353000.0 for Q1 2025.